{"id":"W2921123848","doi":"10.1016/j.pharmthera.2019.03.003","title":"Emerging drug development technologies targeting ubiquitination for cancer therapeutics","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Guelph; University of Toronto","funders":"Canadian Institutes of Health Research; Cancer Research Society; Genome Canada","keywords":"Drug discovery; Proteasome; Cancer; Drug development; Ubiquitin; Medicine; Drug; Cancer therapy; Cancer research; Bioinformatics; Biology; Pharmacology; Cell biology; Internal medicine; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005768608,0.0006929914,0.001019783,0.0001887526,0.0002895182,0.00004219072,0.0007624393,0.0007601071,0.00004930155],"category_scores_gemma":[0.000009015044,0.0006195384,0.0004191709,0.0002016248,0.0001336972,0.000007422704,0.0003026408,0.0005027198,0.00003506864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001442886,"about_ca_system_score_gemma":0.0007972864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000166505,"about_ca_topic_score_gemma":0.000004796547,"domain_scores_codex":[0.9973047,0.0002291673,0.000742764,0.0008027558,0.0001819543,0.0007386972],"domain_scores_gemma":[0.9985992,0.000129561,0.0006387758,0.0003479891,0.0002350357,0.0000493981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003700606,0.00008023949,0.000006969183,0.004544527,0.001725608,0.000001194906,0.0001728163,0.000007622043,0.01315444,0.00002509022,0.001338704,0.9789058],"study_design_scores_gemma":[0.0004592495,0.00008558579,2.205862e-7,0.0004967367,0.001980379,0.00000679085,0.00009929702,0.00004707518,0.08704665,0.00003036906,0.9090925,0.000655175],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002262899,0.9940228,0.0009360016,0.0003923836,0.00156284,0.002428842,0.0001357596,0.0001574756,0.0001376029],"genre_scores_gemma":[0.0002079468,0.9914848,0.002075879,0.001523854,0.0006387646,0.002076126,0.0007311055,0.0001788194,0.001082772],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9782506,"threshold_uncertainty_score":0.9996256,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08099226102202954,"score_gpt":0.3933408033563059,"score_spread":0.3123485423342763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}